Document 0189 DOCN M9590189 TI Towards the ideal clinical trial: a participant's perspective. DT 9509 AU Duffin R; AIDS Council of NSW. SO Annu Conf Australas Soc HIV Med. 1994 Nov 3-6;6:87 (unnumbered abstract). Unique Identifier : AIDSLINE ASHM6/95291910 AB People with HIV have faced the task of trying to make meaning of clinical trials, what they mean and understanding quite complex decisions they face. The enthusiasm for participating in trials has changed. There is now less expectation of rapid advances in HIV medicine. More people have experienced clinical trials and are more aware of what participation means. Recruitment of trial participants is becoming a world wide problem, and if this is to be tackled it requires the active involvement of people with HIV and trials which are relevant to the local environment where they are conducted. The results of ten years experience have not only changed community expectations, but have led to a debate about appropriate trialing strategies and radically different approaches at a national level. Much of clinical trial design focuses on ensuring the removal of bias by either the participant or the researcher. Many other possible sources of bias such as the interface between trial sponsors and clinicians do not receive the same scrutiny. There are many areas where the trial mechanisms within Australia could be reviewed--particularly whether adequate resources exist at this point in the epidemic. However, the benefits to the morale of people with HIV of having effective clinical trials conducted within Australia cannot be understated. DE Australia Bias (Epidemiology) Clinical Trials/*STATISTICS & NUMER DATA Human HIV Infections/*DRUG THERAPY/PSYCHOLOGY Patient Satisfaction Patient Selection Sick Role Treatment Outcome MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).